Home Cart 0 Sign in  

[ CAS No. 626-60-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 626-60-8
Chemical Structure| 626-60-8
Structure of 626-60-8 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 626-60-8 ]

Related Doc. of [ 626-60-8 ]

Alternatived Products of [ 626-60-8 ]
Product Citations

Product Details of [ 626-60-8 ]

CAS No. :626-60-8 MDL No. :MFCD00006375
Formula : C5H4ClN Boiling Point : No data available
Linear Structure Formula :- InChI Key :PWRBCZZQRRPXAB-UHFFFAOYSA-N
M.W : 113.55 Pubchem ID :12287
Synonyms :

Calculated chemistry of [ 626-60-8 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 29.25
TPSA : 12.89 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.05 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.49
Log Po/w (XLOGP3) : 1.33
Log Po/w (WLOGP) : 1.73
Log Po/w (MLOGP) : 1.06
Log Po/w (SILICOS-IT) : 2.15
Consensus Log Po/w : 1.55

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.02
Solubility : 1.09 mg/ml ; 0.00963 mol/l
Class : Soluble
Log S (Ali) : -1.2
Solubility : 7.13 mg/ml ; 0.0628 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.58
Solubility : 0.297 mg/ml ; 0.00262 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.04

Safety of [ 626-60-8 ]

Signal Word:Warning Class:
Precautionary Statements:P210-P241-P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P370+P378-P362+P364-P403+P233-P501 UN#:
Hazard Statements:H227-H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 626-60-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 626-60-8 ]
  • Downstream synthetic route of [ 626-60-8 ]

[ 626-60-8 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 626-60-8 ]
  • [ 22353-34-0 ]
Reference: [1] Roczniki Chemii, 1938, vol. 18, p. 210[2] Chemisches Zentralblatt, 1939, vol. 110, # II, p. 2779
  • 2
  • [ 626-60-8 ]
  • [ 77332-79-7 ]
YieldReaction ConditionsOperation in experiment
0.5 g
Stage #1: With lithium diisopropyl amide In tetrahydrofuran at -75℃; for 4 h;
Stage #2: With iodine In tetrahydrofuran at -75℃; for 1 h;
To a cold solution of 3-chloro pyridine (1.0 g, 8.88 mmol) in THF (30.0 mL) was added LDA (5.9 mL, 8.88 mmol) at -75°C. The reaction mixture was stirred at -75°C for 4 h. Iodine (2.2 g, 8.88 mmol) was added and continued stirring at -75°C for 1 h. The reaction mixture was quenched in water at -70°C, extracted with ethyl acetate and concentrated to afford 0.500 g of desired product. 1H NMR (300 MHz, DMSO d6): δ 8.01 (d, J = 5.1 Hz, 1H), 8.14 (d, / = 4.8 Hz, 1H), 8.63 (s, 1H).
Reference: [1] Angewandte Chemie - International Edition, 2008, vol. 47, # 5, p. 888 - 890
[2] Tetrahedron Letters, 2004, vol. 45, # 42, p. 7873 - 7877
[3] Tetrahedron, 1993, vol. 49, # 1, p. 49 - 64
[4] Patent: US6169086, 2001, A,
[5] Patent: WO2008/57209, 2008, A1, . Location in patent: Page/Page column 54-55
[6] Patent: WO2008/18639, 2008, A2, . Location in patent: Page/Page column 108-109
[7] Patent: WO2013/186692, 2013, A1, . Location in patent: Page/Page column 61; 62
  • 3
  • [ 626-60-8 ]
  • [ 77332-79-7 ]
  • [ 77332-90-2 ]
  • [ 77332-89-9 ]
  • [ 77332-88-8 ]
Reference: [1] Tetrahedron Letters, 1980, vol. 21, # 43, p. 4137 - 4140
[2] Heterocycles, 1993, vol. 35, # 1, p. 151 - 169
[3] Heterocycles, 1993, vol. 35, # 1, p. 151 - 169
[4] Heterocycles, 1993, vol. 35, # 1, p. 151 - 169
  • 4
  • [ 626-60-8 ]
  • [ 437383-99-8 ]
Reference: [1] Archives of Pharmacal Research, 2018, vol. 41, # 12, p. 1149 - 1161
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 626-60-8 ]

Chlorides

Chemical Structure| 55934-00-4

[ 55934-00-4 ]

3,4-Dichloropyridine

Similarity: 0.87

Chemical Structure| 1072-98-6

[ 1072-98-6 ]

2-Amino-5-chloropyridine

Similarity: 0.85

Chemical Structure| 2457-47-8

[ 2457-47-8 ]

3,5-Dichloropyridine

Similarity: 0.85

Chemical Structure| 72093-04-0

[ 72093-04-0 ]

3-Chloro-4-methylpyridine

Similarity: 0.85

Chemical Structure| 19230-55-8

[ 19230-55-8 ]

3-Chloro-5-methylpyridine

Similarity: 0.83

Related Parent Nucleus of
[ 626-60-8 ]

Pyridines

Chemical Structure| 55934-00-4

[ 55934-00-4 ]

3,4-Dichloropyridine

Similarity: 0.87

Chemical Structure| 1072-98-6

[ 1072-98-6 ]

2-Amino-5-chloropyridine

Similarity: 0.85

Chemical Structure| 2457-47-8

[ 2457-47-8 ]

3,5-Dichloropyridine

Similarity: 0.85

Chemical Structure| 72093-04-0

[ 72093-04-0 ]

3-Chloro-4-methylpyridine

Similarity: 0.85

Chemical Structure| 19230-55-8

[ 19230-55-8 ]

3-Chloro-5-methylpyridine

Similarity: 0.83

; ;